Market Price

128.50 

1.80 1.4%

as of Aug 07 '20

52 Week Range:

82.20 133.00


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, enzymes, eubiotics, carotenoids, lipids, and minerals; human nutrition and health products comprising carotenoids, digestive enzymes, nutritional lipids, nutraceuticals, probiotic and prebiotics, and vitamins; and skin and sun care, hair care, and aroma ingredients. It also provides vitamin and lipid active pharmaceutical ingredients; omega-3 fatty acids; specialty enzymes, cultures, probiotics, bio-preservation, sugar reduction, and savory taste solutions; and specialty hydrocolloid solutions. The Materials segment provides thermoplastics used in automotive, electrical and electronics, building and construction, medical, food packaging, and consumer goods; coating resins and functional materials; Dyneema, a fiber solution for use in aviation, personal protection, marine, fishing, heavy lifting, and sports and lifestyle industries; and additives. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, plastic and reconstructive surgery, soft tissue, and wound management. It also provides anti-reflective (AR) coatings for solar glass, retrofit AR and anti-soiling coatings, and conductive and PV backsheets; and yeast and enzymes for the conversion of starch, corn fiber, and biomass. The company has a partnership with Strait Access Technologies to develop trans-catheter replacement heart valves with polymeric leaflets. Koninklijke DSM N.V. was founded in 1902 and is headquartered in Heerlen, the Netherlands.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Equity (BVPS) 30.36
32.93
35.19
34.82
35.04
34.61
31.23
33.33
39.26
43.21
46.76
growth rate 8.5% 6.9% -1.1% 0.6% -1.2% -9.8% 6.7% 17.8% 10.1% 8.2%
Earnings BIT 418.00
714.00
850.00
349.00
725.00
587.00
353.00
625.00
797.00
1,209.00
889.00
growth rate 70.8% 19.1% -58.9% 107.7% -19.0% -39.9% 77.1% 27.5% 51.7% -26.5%
Avg.PE 17.15
14.14
8.90
26.53
24.04
11.46
11.46
17.42
8.09
16.84
27.18
growth rate -17.6% -37.1% 198.1% -9.4% -52.3% 0.0% 52.0% -53.6% 108.2% 61.4%
ROA 3.39
4.95
7.52
2.40
2.18
1.12
0.65
5.00
13.67
8.09
5.54
growth rate 46.0% 51.9% -68.1% -9.2% -48.6% -42.0% 669.2% 173.4% -40.8% -31.5%
ROE 6.83
9.53
14.45
4.77
4.43
2.32
1.38
10.63
27.02
14.50
9.67
growth rate 39.5% 51.6% -67.0% -7.1% -47.6% -40.5% 670.3% 154.2% -46.3% -33.3%
ROIC 5.91
7.62
11.17
4.24
4.23
2.85
2.10
7.91
19.53
11.42
7.95
growth rate 28.9% 46.6% -62.0% -0.2% -32.6% -26.3% 276.7% 146.9% -41.5% -30.4%
Cur. Ratio 2.14
2.51
2.24
1.53
1.48
1.21
1.62
1.59
2.44
2.45
2.42
growth rate 17.3% -10.8% -31.7% -3.3% -18.2% 33.9% -1.9% 53.5% 0.4% -1.2%
Quick Ratio 1.40
1.67
1.60
0.89
0.71
0.66
0.87
0.97
1.54
1.62
1.43
growth rate 19.3% -4.2% -44.4% -20.2% -7.0% 31.8% 11.5% 58.8% 5.2% -11.7%
Leverage 1.94
1.91
1.93
2.04
2.03
2.12
2.12
2.13
1.84
1.75
1.74
growth rate -1.6% 1.1% 5.7% -0.5% 4.4% 0.0% 0.5% -13.6% -4.9% -0.6%
Balance Sheet Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Acct.Receivable 1,410.00
1,477.00
1,551.00
1,794.00
1,591.00
1,761.00
1,552.00
1,651.00
1,688.00
1,737.00
1,696.00
growth rate 4.8% 5.0% 15.7% -11.3% 10.7% -11.9% 6.4% 2.2% 2.9% -2.4%
Acct.Payable 1,412.00
1,263.00
1,355.00
1,164.00
1,370.00
1,448.00
1,425.00
1,338.00
growth rate -10.6% 7.3% -14.1% 17.7% 5.7% -1.6% -6.1%
Cur.Assets 4,229.00
5,241.00
5,504.00
4,841.00
4,787.00
4,267.00
3,915.00
5,041.00
5,432.00
6,310.00
5,224.00
growth rate 23.9% 5.0% -12.1% -1.1% -10.9% -8.3% 28.8% 7.8% 16.2% -17.2%
Total Assets 9,614.00
10,480.00
11,157.00
11,966.00
11,899.00
12,126.00
11,743.00
12,958.00
12,802.00
13,641.00
13,443.00
growth rate 9.0% 6.5% 7.3% -0.6% 1.9% -3.2% 10.4% -1.2% 6.6% -1.5%
Cash 1,340.00
1,453.00
2,058.00
1,121.00
770.00
669.00
665.00
604.00
899.00
1,281.00
800.00
growth rate 8.4% 41.6% -45.5% -31.3% -13.1% -0.6% -9.2% 48.8% 42.5% -37.6%
Inventory 1,359.00
1,340.00
1,573.00
1,803.00
1,638.00
1,739.00
1,627.00
1,800.00
1,848.00
1,993.00
2,019.00
growth rate -1.4% 17.4% 14.6% -9.2% 6.2% -6.4% 10.6% 2.7% 7.9% 1.3%
Cur.Liabilities 1,972.00
2,170.00
2,455.00
3,159.00
3,205.00
3,523.00
2,414.00
3,158.00
2,228.00
2,571.00
2,163.00
growth rate 10.0% 13.1% 28.7% 1.5% 9.9% -31.5% 30.8% -29.5% 15.4% -15.9%
Liabilities 4,665.00
4,999.00
5,373.00
5,924.00
5,803.00
6,190.00
6,112.00
6,778.00
5,737.00
5,826.00
5,608.00
growth rate 7.2% 7.5% 10.3% -2.0% 6.7% -1.3% 10.9% -15.4% 1.6% -3.7%
LT Debt 2,066.00
1,992.00
2,029.00
1,919.00
1,724.00
1,637.00
2,557.00
2,548.00
2,547.00
2,252.00
2,277.00
growth rate -3.6% 1.9% -5.4% -10.2% -5.1% 56.2% -0.4% 0.0% -11.6% 1.1%
Equity 4,949.00
5,481.00
5,974.00
6,042.00
5,908.00
5,723.00
5,541.00
6,072.00
6,962.00
7,782.00
7,731.00
growth rate 10.8% 9.0% 1.1% -2.2% -3.1% -3.2% 9.6% 14.7% 11.8% -0.7%
Common Shares 163.00
165.00
167.00
167.00
173.00
173.00
175.00
176.00
175.00
176.00
177.00
growth rate 1.2% 1.2% 0.0% 3.6% 0.0% 1.2% 0.6% -0.6% 0.6% 0.6%
Cash Flow Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Capital Expenditures 377.00
363.00
415.00
604.00
566.00
556.00
458.00
413.00
449.00
565.00
520.00
growth rate -3.7% 14.3% 45.5% -6.3% -1.8% -17.6% -9.8% 8.7% 25.8% -8.0%
Cash Dividends 205.00
206.00
155.00
210.00
160.00
175.00
174.00
190.00
200.00
225.00
291.00
growth rate 0.5% -24.8% 35.5% -23.8% 9.4% -0.6% 9.2% 5.3% 12.5% 29.3%
Cash From OA 1,276.00
1,103.00
882.00
730.00
998.00
808.00
696.00
1,018.00
996.00
1,391.00
1,385.00
growth rate -13.6% -20.0% -17.2% 36.7% -19.0% -13.9% 46.3% -2.2% 39.7% -0.4%
FCF per Share 5.03
4.16
2.53
0.26
-0.42
0.31
0.90
2.76
2.46
3.74
4.35
growth rate -17.3% -39.2% -89.7% -100.0% 100.0% 190.3% 206.7% -10.9% 52.0% 16.3%
Sale Purchase of Stock 145.00
26.00
39.00
137.00
107.00
growth rate -82.1% 50.0% 251.3% -21.9%
FCF 819.00
687.00
405.00
44.00
154.00
155.00
153.00
523.00
441.00
698.00
744.00
growth rate -16.1% -41.1% -89.1% 250.0% 0.7% -1.3% 241.8% -15.7% 58.3% 6.6%
Income Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Sales 7,866.00
8,176.00
9,193.00
8,588.00
8,858.00
7,051.00
7,722.00
7,920.00
8,632.00
9,267.00
9,010.00
growth rate 3.9% 12.4% -6.6% 3.1% -20.4% 9.5% 2.6% 9.0% 7.4% -2.8%
Op.Income 535.00
764.00
928.00
300.00
725.00
587.00
353.00
625.00
797.00
1,209.00
889.00
growth rate 42.8% 21.5% -67.7% 141.7% -19.0% -39.9% 77.1% 27.5% 51.7% -26.5%
IBT 418.00
676.00
989.00
373.00
337.00
164.00
228.00
746.00
1,896.00
1,273.00
916.00
growth rate 61.7% 46.3% -62.3% -9.7% -51.3% 39.0% 227.2% 154.2% -32.9% -28.0%
Net Income 317.00
507.00
814.00
300.00
271.00
145.00
88.00
621.00
1,769.00
1,077.00
758.00
growth rate 59.9% 60.6% -63.1% -9.7% -46.5% -39.3% 605.7% 184.9% -39.1% -29.6%
EPS 2.01
3.01
4.82
1.61
1.51
0.78
0.45
3.51
10.04
6.06
4.24
growth rate 49.8% 60.1% -66.6% -6.2% -48.3% -42.3% 680.0% 186.0% -39.6% -30.0%
Gross Profit 1,774.00
2,252.00
2,568.00
2,368.00
2,458.00
2,248.00
2,309.00
2,658.00
2,933.00
3,405.00
3,053.00
growth rate 26.9% 14.0% -7.8% 3.8% -8.5% 2.7% 15.1% 10.4% 16.1% -10.3%
R&D 305.00
328.00
381.00
374.00
340.00
304.00
332.00
309.00
334.00
348.00
349.00
growth rate 7.5% 16.2% -1.8% -9.1% -10.6% 9.2% -6.9% 8.1% 4.2% 0.3%

Quarterly Statements

Item Name Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Earnings BIT 279.00
289.00
276.00
47.00
272.00
growth rate 3.6% -4.5% -83.0% 478.7%
Balance Sheet Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Acct.Receivable 1,985.00
1,876.00
1,864.00
1,696.00
1,890.00
growth rate -5.5% -0.6% -9.0% 11.4%
Acct.Payable 1,471.00
1,452.00
1,365.00
1,338.00
1,554.00
growth rate -1.3% -6.0% -2.0% 16.1%
Cur.Assets 6,553.00
6,266.00
5,792.00
5,224.00
5,639.00
growth rate -4.4% -7.6% -9.8% 7.9%
Total Assets 14,289.00
13,901.00
13,812.00
13,443.00
13,814.00
growth rate -2.7% -0.6% -2.7% 2.8%
Cash 1,043.00
1,137.00
926.00
800.00
1,396.00
growth rate 9.0% -18.6% -13.6% 74.5%
Inventory 2,065.00
2,071.00
2,118.00
2,019.00
2,137.00
growth rate 0.3% 2.3% -4.7% 5.8%
Cur.Liabilities 2,676.00
2,695.00
2,207.00
2,163.00
2,698.00
growth rate 0.7% -18.1% -2.0% 24.7%
Liabilities 6,063.00
6,061.00
5,650.00
5,608.00
6,151.00
growth rate 0.0% -6.8% -0.7% 9.7%
LT Debt 2,227.00
2,255.00
2,242.00
2,277.00
2,470.00
growth rate 1.3% -0.6% 1.6% 8.5%
Equity 8,169.00
7,786.00
8,063.00
7,731.00
7,560.00
growth rate -4.7% 3.6% -4.1% -2.2%
Common Shares 8,169.00
7,786.00
8,063.00
338.00
7,560.00
growth rate -4.7% 3.6% -95.8% 2,136.7%
Cash Flow Statement Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Capital Expenditures 150.00
119.00
151.00
100.00
152.00
growth rate -20.7% 26.9% -33.8% 52.0%
Cash Dividends 17.00
14.00
14.00
14.00
6.00
growth rate -17.7% 0.0% 0.0% -57.1%
Cash From OA 201.00
306.00
434.00
444.00
287.00
growth rate 52.2% 41.8% 2.3% -35.4%
Sale Purchase of Stock
growth rate
FCF 51.00
187.00
283.00
344.00
135.00
growth rate 266.7% 51.3% 21.6% -60.8%
Income Statement Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Sales 2,292.00
2,276.00
2,290.00
2,152.00
2,293.00
growth rate -0.7% 0.6% -6.0% 6.6%
Op.Income 279.00
289.00
276.00
47.00
272.00
growth rate 3.6% -4.5% -83.0% 478.7%
IBT 240.00
241.00
281.00
154.00
198.00
growth rate 0.4% 16.6% -45.2% 28.6%
Net Income 195.00
204.00
236.00
123.00
167.00
growth rate 4.6% 15.7% -47.9% 35.8%
EPS
growth rate
Gross Profit 2,292.00
2,276.00
2,290.00
-3,805.00
2,293.00
growth rate -0.7% 0.6% -100.0% 100.0%
R&D 349.00
349.00
349.00
349.00
growth rate 0.0% 0.0% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (44.47)

YOY Growth Grade:

E (19.18)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 26.08 30.31 22.25
EPS / Growth 7.9% 4.24 12.5%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 4.8%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 4.8% 8.4% 8.4%
Future PE 9.58 21.72 21.72
Future EPS 6.77 9.51 9.51
Value Price
MOS %
16.03
-87.5%
51.04
-60.3%
51.04
-60.3%
MOS Price 8.02 25.52 25.52
IRT 18.57 14.97 14.97

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.